Kerri Fitzgerald

DocwireNews

Here are the top stories covered by DocWire News&nbsp;this week in the Hematology &amp; Oncology section. This week, a report indicated that where you live impacts your chances of surviving lung cancer, ruxolitinib is associated with worsening cardiometabolic health, and more.<a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/brca2-incidence-in-men-associated-with-increased-prostate-cancer-risk/">Men with the&nbsp;BRCA2&nbsp;mutation</a> have an increased risk of&nbsp;prostate cancer&nbsp;compared with non-BRCA2&nbsp;carriers and should undergo regular prostate-specific antigen testing, according to interim research from the IMPACT study, presented at the National Cancer Research Institute 2019 Cancer Conference. The results were also published in&nbsp;European Urology.In the past decade, <a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/u-s-lung-cancer-survival-improving-but-still-linked-to-where-you-live/">new&nbsp;lung cancer&nbsp;cases have decreased by 19%</a> and five-year survival has increased by 26%, according to a promising report from the&nbsp;American Lung Association. Despite this,&nbsp;lung cancer&nbsp;remains the leading cause of death in the United States, and the chance of surviving the disease is largely dictated by where a person lives.<a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/secondary-cancer-does-not-prolong-survival-for-ovarian-cancer/">Secondary surgical cytoreduction</a> followed by chemotherapy does not extend overall survival (primary endpoint) compared with chemotherapy alone in patients with platinum-sensitive, recurrent ovarian cancer, according to a study published in&nbsp;The New England Journal of Medicine.<a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/simple-blood-test-may-detecteyemelanoma/">Melanoma of the eye may soon be detected</a> using a simple test, according to a study that&nbsp;appeared in&nbsp;Translational Vision Science &amp; Technology.Ruxolitinib, an oral JAK1/2 inhibitor approved by the U.S. Food and Drug Administration for the treatment of myeloproliferative neoplasms, <a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/ruxolitinib-for-myeloproliferative-neoplasms-worsens-cardiometabolic-health/">is associated with worsening&nbsp;cardiometabolic health</a>, according to an article published in&nbsp;Scientific Reports.In case you missed it, more hem/onc headlines are featured below:<ul>
<li><a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/bite-treatment-has-promising-outcomes-in-her2-cancers/">BiTE Treatment Has Promising Outcomes in HER2+ Cancers</a></li>
<li><a href="https://www.docwirenews.com/home-page-editor-picks/family-history-of-cancer-linked-to-childhoodasthma/">Family History of Cancer Linked to Childhood Asthma</a></li>
<li><a href="https://www.docwirenews.com/hematology-oncology/racial-disparities-in-lung-cancer-care/">Racial Disparities in Lung Cancer Care</a></li>
<li><a href="https://www.docwirenews.com/hematology-oncology/improving-patient-caregiver-communication-in-older-cancer-patients/">Improving Patient-Caregiver Communication in Older Cancer Patients</a></li>
<li><a href="https://www.docwirenews.com/docwire-pick/cardiology-picks/heart-disease-cancer-risk-linked/">Heart Disease and Cancer Risk May Be Linked</a></li>
</ul>

Bradley Marder, MD

Joel M. Topf, MD, FACP

Gout Studies: Transplant Waitlisting and Bone Erosion

NKF Spring Clinical Meetings 2025

Jayme Locke, MD, MPH

The Promise of Xenotransplantation

Leah Lawrence

Real-World Data Backs Invasive DFS as Surrogate Endpoint for OS in EBC

HR Breast Cancer

Latest News

Hem/Onc Roundup: BRCA2 Mutation and Prostate Cancer, Cancer Drug Affects Cardio Health, and more

Oncology

Here are the top stories covered by DocWire News this week in the Hematology &amp; Oncology section. This week, a report indicated that where you live impacts your chances of ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe